Navigation Links
Reportlinker Adds Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market
Date:5/26/2011

is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

GBI Research analysis shows that the overall global opioids market for the seven indications fibromyalgia, neuropathic pain, cancer pain, osteoarthritis pain, rheumatoid arthritis pain, low back pain and post operative pain was valued at $11.2 billion in 2010. The market is expected to witness a CAGR of 2.8% for the forecast period. Patent expiries of leading opioids followed by generic erosions along with adverse effects associated with use of opioids are the main reasons for marginal growth in opioids market. However expected launch of new opioids is expected to push the market in future.

The US was the largest region for the opioids market in terms of revenue, accounting for 49% followed by top five countries in Europe and Japan which contributed 36% and 15% respectively.

The top pharmaceutical companies in opioids market are – Johnson & Johnson, Cephalon and several mid size players such as Purdue Pharma, King Pharmaceuticals, Orexo and Endo Pharmaceuticals. Large amount of fragmentation in the market provides significant scope for consolidation through mergers and acquisitions.

Scope

The scope of this report includes -

- Data and analysis on the global opioids market.

- Annualized market data for the opioids market from 2002 to 2010, with forecasts to 2017.

- Market data on the therapeutic landscape which covers fibromyalgia, neuropathic pain, cancer pain, osteoarthritis pain, rheumatoid arthritis pain, low back pain and post operative pain therapeutics including market size, market share, annual cost of therapy, sales volume and treatment usage patterns such as disease population and treated population.

- Key drivers and restraints that have had a significant impact on the market and on each indication.

-
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Reportlinker Adds US Disposable Medical Supplies Market Report
2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
7. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
8. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
9. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
10. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... -- Xencor Inc. (NASDAQ: XNCR ), ... for the treatment of autoimmune diseases, asthma and ... for the second quarter ended June 30, 2014 and ... "In the second quarter, we presented preclinical ... Conference (ATS) demonstrating three novel mechanisms of action ...
(Date:7/31/2014)... , July 31, 2014   Auxilium Pharmaceuticals , ... specialty biopharmaceutical company, today announced that the Company will ... Thursday, August 7, 2014 before the opening of the ... conference call that day at 8:30 a.m. ET to ... 2014. The presentation slides to be used during the ...
(Date:7/31/2014)...  A substantial share of pharmacy and therapeutics ... are included in formularies—say patient support resources from ... Manhattan Research study, Taking the Pulse® Formulary ... P&T committee members in hospitals, managed care organizations ... a high bar for these programs, requiring that ...
Breaking Medicine Technology:Xencor Reports Second Quarter 2014 Financial Results 2Xencor Reports Second Quarter 2014 Financial Results 3Xencor Reports Second Quarter 2014 Financial Results 4Xencor Reports Second Quarter 2014 Financial Results 5Xencor Reports Second Quarter 2014 Financial Results 6Xencor Reports Second Quarter 2014 Financial Results 7Xencor Reports Second Quarter 2014 Financial Results 8Auxilium Pharmaceuticals, Inc. To Announce Second Quarter 2014 Results On August 7, 2014 2Auxilium Pharmaceuticals, Inc. To Announce Second Quarter 2014 Results On August 7, 2014 3Formulary Decision Makers Say Pharma-Provided Patient Support Solutions Influence Formulary Placement 2Formulary Decision Makers Say Pharma-Provided Patient Support Solutions Influence Formulary Placement 3
... CHICAGO , June 5 Scientists from ... presented preliminary data that shows nitrogen-containing bisphosphonates, therapeutic agents used ... slightly poorer survival rate in post-menopausal women with early stage ... findings were announced today at the 2010 American Society of ...
... BARBARA, Calif. , June 4 Abviva, Inc. (Pink ... of breast cancer related applications of Mammastatin, today provided further details ...   , , , ... appoints W.T. Uniack & Co. as its independent auditor. ...
Cached Medicine Technology:Karmanos Cancer Institute Researchers Study Bisphosphonates and Their Affect on Early Stage Breast Cancer 2Karmanos Cancer Institute Researchers Study Bisphosphonates and Their Affect on Early Stage Breast Cancer 3Karmanos Cancer Institute Researchers Study Bisphosphonates and Their Affect on Early Stage Breast Cancer 4Abviva Engages W.T. Uniack & Co. As Independent Auditor 2
(Date:7/31/2014)... July 31, 2014 In today’s world, a ... to get. Snoring and sleep apnea (a medical problem where ... and their bed partners of the rest they need to ... the population snores and 20 million people in the United ... been diagnosed and treated; and of those treated, many cannot ...
(Date:7/31/2014)... NV (PRWEB) July 31, 2014 Niche Profit ... Adam Short that is designed to provide a blueprint for ... the attention of Shane Michaels, prompting an investigative review. ... , “What really speaks volumes about the success of the ... and strategies included in it have stayed effective even through ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 Hook Your Ex, a ... get ex’s to feel emotionally hungry for their partner, to the ... chance. This little trick has been taught to hundreds of ... a quick Hook Your Ex review , Shane Michaels agrees ... suffering pain from a breakup a second chance at getting back ...
(Date:7/31/2014)... CA (PRWEB) July 31, 2014 Cosmetic ... benefit both patients and doctors. Doctors will be able ... to leave reviews , which guarantees their authenticity. ... options on the site to receive information that has ... This unprecedented validation system allows Cosmetic Town to filter ...
(Date:7/31/2014)... Farmington, NY (PRWEB) July 31, 2014 ... restaurants incorporating Pioneer Millworks’ reclaimed wood to create ... the environment. Their newest location features reclaimed ... the restaurant, with custom selected mixed softwoods flowing ... trusses crafted by Pioneer Millworks’ sister company ...
Breaking Medicine News(10 mins):Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:Niche Profit Classroom: Review Exposes Adam Short’s Guide to Building Niche Websites 2Health News:Hook Your Ex Review by Shane Michaels Exposes Steve Pratt And His New Method For Getting Back With The Ex 2Health News:Cosmetic Town Improves Patient Experience Through Secure Verification of Patients and Doctors 2Health News:Popular Tavern Restaurant Features Pioneer Millworks’ Reclaimed Wood in New Locations 2
... have raised questions regarding differences in quality of care ... In fact, a growing body of health services research ... the weekend and increased mortality. This "weekend effect" has ... specific intensive treatments and procedures. , Two recent studies ...
... the March 1 issue of the journal SLEEP ... promising model for addressing adolescent sleep problems, given ... healthy sleep knowledge and practice. , The program, ... period, had a high retention rate of 83 percent ...
... green vegetables such as broccoli and cabbage could ... cancer researchers. Tests on mice suggest that these ... safely and effectively than conventional therapy. , "There ... that trigger melanoma," said Gavin Robertson, associate professor ...
... Bethesda, MD (March 1, 2009) Although the ... is well established, studies investigating the association between ... (BE) and esophageal adenocarcinoma (EAC) have reported inconsistent ... of alcohol on BE, especially related to alcohol ...
... Brian Schweitzer, Chair of the Democratic Governors Association, today ... Gov. Kathleen Sebelius as Secretary of Health and Human ... Kathleen Sebelius is an excellent choice to lead the ... our health care system, Governor Sebelius will bring a ...
... precautions should be abandoned, experts note , , SATURDAY, ... trip is as important as packing the right clothes. ... doesn,t mean it,s safe," Laura Gonzalez, a nurse with The ... said in a news release issued by the school. "You ...
Cached Medicine News:Health News:Patients with GI bleeding admitted on the weekend have higher death rate 2Health News:Patients with GI bleeding admitted on the weekend have higher death rate 3Health News:School-based intervention is a promising model for improving adolescent sleep habits 2Health News:School-based intervention is a promising model for improving adolescent sleep habits 3Health News:Vegetable-based drug could inhibit melanoma 2Health News:Alcohol types and socioeconomic status are associated with Barrett's esophagus risk 2Health News:Alcohol types and socioeconomic status are associated with Barrett's esophagus risk 3Health News:Travel Safety Can Be a Passport to Good Health 2
Lyphochek Therapeutic Drug Monitoring Control (TDM) contains over 40 analytes with assayed values at three clinically significant levels....
Lyphochek Endocrine Control is a human based product designed to monitor plasma catecholamine testing procedures by HPLC. The analytes are spiked at critical concentrations to cover the dynamic range...
Lyphochek Urine Metals Control incorporates two levels of critical trace elements, heavy metals and organic metabolites, and is ideal for environmental and industrial testing....
Lyphochek Whole Blood Control is a unique product designed to monitor immunosuppressants, red cell folate and lead in whole blood assays. This control has three critical levels for each analyte and i...
Medicine Products: